Candriam Equities L Biotechnology Class R USD CapRegister to Unlock Ratings |
Growth Of 1000 (GBP) | 30/04/2024 |
|
Annual Returns (GBP) | 30/04/2024 | |||||||
2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 30/04 | |
Price Return | 16.66 | -5.01 | 30.78 | 16.47 | -1.00 | 11.79 | 2.00 | -1.61 |
+/- Category | 6.36 | 2.96 | 10.58 | -9.50 | 8.03 | 19.63 | 3.29 | 2.11 |
+/- Category Index | 1.47 | -3.16 | 14.07 | -16.46 | -1.30 | 9.33 | -5.33 | -8.05 |
% Rank in Category | 20 | 32 | 8 | 69 | 35 | 2 | 29 | 35 |
Trailing Returns (GBP) | 02/05/2024 | ||
Total Returns | +/- Category | +/- Category Index | |
1 Day | 2.95 | 1.76 | 3.62 |
1 Week | 4.22 | -1.29 | 3.30 |
1 Month | -0.27 | 0.37 | -0.05 |
3 Months | -0.74 | -3.08 | -5.80 |
6 Months | 14.35 | -1.92 | 0.31 |
YTD | 1.53 | 1.09 | -5.36 |
1 Year | 7.59 | 2.68 | -5.26 |
3 Years Annualised | 5.91 | 10.42 | -1.29 |
5 Years Annualised | 10.09 | 3.51 | -1.96 |
10 Years Annualised | 12.42 | 2.80 | 0.75 |
Category: Sector Equity Biotechnology | |||
Category Index: Morningstar Gbl Biotechnology NR USD |
Quarterly Returns (GBP) | 30/04/2024 | |||
Quarter 1 | Quarter 2 | Quarter 3 | Quarter 4 | |
2024 | 3.96 | - | - | - |
2023 | -5.14 | 0.12 | -1.13 | 8.63 |
2022 | -3.81 | 0.14 | 13.66 | 2.11 |
2021 | -5.80 | 6.81 | 0.61 | -2.21 |
2020 | -5.15 | 25.26 | -5.69 | 3.95 |
2019 | 14.08 | 1.91 | -5.67 | 19.25 |
|
Advertisement |